Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cefuroxime Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112679525B reveals a novel D-7ACA route for cefuroxime acid. Enhanced stability and crystal size offer cost reduction in API manufacturing.
Patent CN109988183B details an eco-friendly route for cefuroxime acid intermediate DCC, eliminating DMAC and reducing waste for reliable supply.
Patent CN101289456B details enzymatic hydrolysis for higher yield and stability. Offers cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN109988183A reveals a green synthesis route for DCC using triphosgene, eliminating DMAC solvent for reduced cost and higher purity in pharmaceutical manufacturing.
Discover the patented CN102134252B process for synthesizing >99% pure cefuroxime acid. Learn how ternary solvent extraction reduces lactone impurities and ensures supply chain stability.
Patent CN112707919B introduces a graphene-supported copper catalyst for synthesizing 3-decarbamoyl cefuroxime acid, offering high purity and reduced phosphorus waste.
Advanced low-temperature selective hydrolysis method for cefuroxime acid production. High purity, reduced waste, and scalable manufacturing for global pharmaceutical supply chains.
Patent CN1364169A reveals a safer carbamylation process for Cefuroxime acid using dimethyl carbonate, offering high purity and reduced toxicity for antibiotic manufacturing.
Advanced preparation method for high-purity cefuroxime acid using ternary solvent extraction. Achieves >99% purity for antibiotic manufacturing with optimized supply chain efficiency.